TAK-385
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for TAK-385, covering 2013-01-21 to 2020-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis [Phase 3]